This might be due to the strong expression of the PPIX efflux transporter gene Abcg2 in C2 tumors and the C2 tumor cell line (Figure S1) and could explain the dose-limiting side effects seen in the mice after PDT. This evidence concerns the gene ABCG2 and neoplasm.